Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Prevention of the cardiotoxic effects of adriamycin and daunomycin in the isolated dog heart.

× No keyword cloud information.

9 in total

1. Preventing the cardiotoxicity of anthracyclines by dexrazoxane.

Authors: K Hellmann
Journal: BMJ Date: 1999-10-23

2. Inhibition of adriamycin cardiotoxicity by acetyldaunomycin.

Authors: G Zbinden
Journal: Experientia Date: 1975-09-15

Review 3. Anthracyclines: cardiotoxicity and its prevention.

Authors: J P Hale; I J Lewis
Journal: Arch Dis Child Date: 1994-11 Impact factor: 3.791

Review 4. A risk-benefit assessment of anthracycline antibiotics in antineoplastic therapy.

Authors: R Abraham; R L Basser; M D Green
Journal: Drug Saf Date: 1996-12 Impact factor: 5.606

5. Visnagin-a new protectant against doxorubicin cardiotoxicity? Inhibition of mitochondrial malate dehydrogenase 2 (MDH2) and beyond.

Authors: Lei Xi
Journal: Ann Transl Med Date: 2016-02

6. Phase I clinical trial and pharmacokinetics of weekly ICRF-187 (NSC 169780) infusion in patients with solid tumors.

Authors: C L Vogel; E Gorowski; E Davila; M Eisenberger; J Kosinski; R P Agarwal; N Savaraj
Journal: Invest New Drugs Date: 1987 Impact factor: 3.850

Review 7. Cardioprotection by dexrazoxane (Cardioxane; ICRF 187): progress in supportive care.

Authors: K Hellmann
Journal: Support Care Cancer Date: 1996-07 Impact factor: 3.603

Review 8. Adriamycin (doxorubicin) cardiotoxicity: a review.

Authors: R T Chlebowski
Journal: West J Med Date: 1979-11

Review 9. Oxidative stress, redox signaling, and metal chelation in anthracycline cardiotoxicity and pharmacological cardioprotection.

Authors: Martin Stěrba; Olga Popelová; Anna Vávrová; Eduard Jirkovský; Petra Kovaříková; Vladimír Geršl; Tomáš Simůnek
Journal: Antioxid Redox Signal Date: 2012-10-12 Impact factor: 8.401

9 in total